Table 2 Distribution of demographic, clinical, and pathological variables of breast cancer patients as a function of PAR1 expression
From: PAR1 is selectively over expressed in high grade breast cancer patients: a cohort study
Variable | PAR1*(+) | PAR1* (-) |
|---|---|---|
Age (years) | 50 (23–77) | 47 (31–58) |
Age at menarche (years) | 13 (11–16) | 13 (12–15) |
Age at first birth (years) | 23 (18–34) | 22 (19–33) |
Parity | 3 (0–12) | 2 (0–8) |
Breastfeeding (>3 months) | 15/29 (52%) | 14/21 (67%) |
Clinically positive axillary nodes | 19/29 (66%) | 15/21 (71%) |
Hormonal status† | ||
Pre-menopausal | 15/29 (52%) | 11/21 (52%) |
Post-menopausal | 14/29 (48%) | 10/21(48%) |
Tumour diameter (cm) | 7 (2–25) | 6 (2–8) |
ER‡ (+) | 15/29 (52%) | 10/21 (48%) |
Total (NT = 50) | 29 | 21 |